Ignite Creation Date:
2024-05-06 @ 3:08 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02219789
Status:
COMPLETED
Last Update Posted:
2018-10-03
First Post:
2014-08-15
Brief Title:
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Sponsor:
Organization:
Mayo Clinic